Orthofix Medical Inc expected to post a loss of 27 cents a share - Earnings Preview

Orthofix Medical

02/05/2025 14:32

Orthofix Medical Inc OFIX.OQ OFIX.O is expected to show a rise in quarterly revenue when it reports  results on May 6 for the period ending March 31 2025

The Lewisville Texas-based  company is expected to report a 1.3% increase in revenue to $191.098 million from $188.61 million a year ago, according to the mean estimate from 6 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Orthofix Medical Inc is for a loss of 27 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Orthofix Medical Inc is $24.00​, above​ its last closing price of $13.55. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Dec. 31 2024
-0.07
-0.05
0.02
Beat
140
Sep. 30 2024
-0.12
-0.15
0.07
Beat
146.7
Jun. 30 2024
-0.21
-0.19
0.05
Beat
125.9​
Mar. 31 2024
-0.34
-0.33
-0.13
Beat
61
​​Dec. 31 2023
-0.07
-0.08
0.02
Beat
126.2
Sep. 30 2023
-0.21
-0.21
0.07
Beat
133.5​
Jun. 30 2023
-0.45
-0.47
0.02
Beat
104.2
Mar. 31 2023
-0.52
-0.51
-0.10
Beat
80.4

This summary was machine generated May 2 at 13:32 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)